| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
phenotype | 0.100 | None | 1.000 | 66 | 0 | 1992 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 59 | 1 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.100 | None | 1.000 | 54 | 1 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 51 | 1 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 51 | 0 | 2005 | 2020 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 49 | 0 | 2008 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 49 | 0 | 1997 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.100 | None | 1.000 | 47 | 0 | 2002 | 2020 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 45 | 0 | 1999 | 2020 | ||||||||
|
galectin 3 | 0.392 | 0.846 | 2.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 45 | 0 | 1993 | 2020 | ||||||||
|
caveolin 1 | 0.388 | 0.885 | 8.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 44 | 0 | 2002 | 2019 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 43 | 0 | 1995 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.100 | None | 1.000 | 42 | 0 | 2000 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
phenotype | 0.100 | None | 1.000 | 39 | 0 | 2009 | 2020 | |||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 37 | 1 | 1993 | 2020 | ||||||||
|
basigin (Ok blood group) | 0.458 | 0.769 | 2.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 37 | 0 | 2000 | 2019 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 35 | 0 | 2005 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.100 | None | 1.000 | 34 | 0 | 1998 | 2019 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 30 | 0 | 2000 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.100 | None | 1.000 | 30 | 0 | 1995 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
phenotype | 0.100 | None | 1.000 | 28 | 0 | 2005 | 2019 | ||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
phenotype | 0.100 | None | 1.000 | 27 | 0 | 1990 | 2019 | ||||||||
|
pyruvate kinase M1/2 | 0.482 | 0.808 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 27 | 0 | 2012 | 2020 | ||||||||
|
HOX transcript antisense RNA | 0.475 | 0.769 |
|
phenotype | 0.100 | None | 1.000 | 26 | 0 | 2011 | 2019 | |||||||||
|
forkhead box M1 | 0.441 | 0.769 | 7.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 25 | 0 | 2004 | 2020 |